Fine-Feature Modifications to Strained Ruthenium Complexes Radically Alter Their Hypoxic Anticancer Activity†

被引:25
作者
Cole, Houston D. [1 ]
Roque, John A., III [1 ,2 ]
Lifshits, Liubov M. [1 ]
Hodges, Rachel [2 ]
Barrett, Patrick C. [2 ]
Havrylyuk, Dmytro [3 ]
Heidary, David [3 ]
Ramasamy, Elamparuthi [1 ]
Cameron, Colin G. [1 ]
Glazer, Edith C. [3 ]
McFarland, Sherri A. [1 ]
机构
[1] Univ Texas Arlington, Dept Chem & Biochem, Arlington, TX 76019 USA
[2] Univ N Carolina, Dept Chem & Biochem, Greensboro, NC 27412 USA
[3] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA
基金
美国国家卫生研究院; 加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
COORDINATION-COMPOUNDS; PHOTOCHEMISTRY; PHOTOPHYSICS; THERAPY; RELEASE; RU(II); DNA; LUMINESCENT; INHIBITORS; BINDING;
D O I
10.1111/php.13395
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In an earlier study of pi-expansive ruthenium complexes for photodynamic and photochemo-therapies, it was shown that a pair of structural isomers differing only in the connection point of a naphthalene residue exhibited vastly different biological activity. These isomers are further explored in this paper through the activity of their functionalized derivatives. In normoxia, the inactive 2-NIP isomer (5) can be made as photocytotoxic as the active 1-NIP isomer (1) by functionalizing with methyl or methoxy groups, while methoxy variants of the 1-NIP isomer became inactive. In all cases, the singlet oxygen sensitization quantum yield was below 1%. Hypoxic photocytotoxicity was attenuated, with only three of the series showing any activity, notwithstanding the photodissociative ligands. The results here are consistent with the earlier findings in that seemingly minor structural modifications on the non-strained ligand can dramatically modulate the normoxic and hypoxic activity of these strained compounds and that these changes appear to exert a greater influence on photocytotoxicity than singlet oxygen sensitization or rates of photosubstitution in cell-free conditions would suggest.
引用
收藏
页码:73 / 84
页数:12
相关论文
共 68 条
[1]   Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers [J].
Arora, Karan ;
Herroon, Mackenzie ;
Al-Afyouni, Malik H. ;
Toupin, Nicholas P. ;
Rohrabaugh, Thomas N., Jr. ;
Loftus, Lauren M. ;
Podgorski, Izabela ;
Turro, Claudia ;
Kodanko, Jeremy J. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2018, 140 (43) :14367-14380
[2]  
Balzani V, 1998, COORDIN CHEM REV, V171, P3
[3]   Photochemistry and photophysics of Ru(II)-polypyridine complexes in the Bologna group. From early studies to recent developments [J].
Balzani, V ;
Juris, A .
COORDINATION CHEMISTRY REVIEWS, 2001, 211 :97-115
[4]   Luminescent and redox-active polynuclear transition metal complexes [J].
Balzani, V ;
Juris, A ;
Venturi, M ;
Campagna, S ;
Serroni, S .
CHEMICAL REVIEWS, 1996, 96 (02) :759-833
[5]  
Berlman I., 1971, MOLECULES, V1971, P5
[6]   Exploring the Phototoxicity of Hypoxic Active Iridium(III)-Based Sensitizers in 3D Tumor Spheroids [J].
Bevernaegie, Robin ;
Doix, Bastien ;
Bastien, Estelle ;
Diman, Aurelie ;
Decottignies, Anabelle ;
Feron, Olivier ;
Elias, Benjamin .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2019, 141 (46) :18486-18491
[7]   Why develop photoactivated chemotherapy? [J].
Bonnet, Sylvestre .
DALTON TRANSACTIONS, 2018, 47 (31) :10330-10343
[8]   Photochemistry and photophysics of coordination compounds: Ruthenium [J].
Campagna, Sebastiano ;
Puntoriero, Fausto ;
Nastasi, Francesco ;
Bergamini, Giacomo ;
Balzani, Vincenzo .
PHOTOCHEMISTRY AND PHOTOPHYSICS OF COORDINATION COMPOUNDS I, 2007, 280 :117-214
[9]  
Casas A., 2015, Resistance to photodynamic therapy in cancer, V5, P29, DOI [DOI 10.1007/978-3-319-12730-92, 10.1007/978-3-319-12730-9_2]
[10]   Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization [J].
Celli, Jonathan P. ;
Spring, Bryan Q. ;
Rizvi, Imran ;
Evans, Conor L. ;
Samkoe, Kimberley S. ;
Verma, Sarika ;
Pogue, Brian W. ;
Hasan, Tayyaba .
CHEMICAL REVIEWS, 2010, 110 (05) :2795-2838